相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior
Yang Zhan et al.
NATURE NEUROSCIENCE (2014)
Distributed BOLD and CBV-weighted resting-state networks in the mouse brain
Francesco Sforazzini et al.
NEUROIMAGE (2014)
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals
F. Errico et al.
TRANSLATIONAL PSYCHIATRY (2014)
Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia
Francesco Errico et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Decreased levels of free D-aspartic acid in the forebrain of serine racemase (Srr) knock-out mice
Mao Horio et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers
S. De Simoni et al.
NEUROIMAGE (2013)
THE LOW-FREQUENCY BLOOD OXYGENATION LEVEL-DEPENDENT FUNCTIONAL CONNECTIVITY SIGNATURE OF THE HIPPOCAMPAL-PREFRONTAL NETWORK IN THE RAT BRAIN
A. J. Schwarz et al.
NEUROSCIENCE (2013)
Neuroimaging Evidence of Major Morpho-Anatomical and Functional Abnormalities in the BTBR T plus TF/J Mouse Model of Autism
Luca Dodero et al.
PLOS ONE (2013)
Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis
Andrea de Bartolomeis et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Quantifying the Attenuation of the Ketamine Pharmacological Magnetic Resonance Imaging Response in Humans: A Validation Using Antipsychotic and Glutamatergic Agents
O. M. Doyle et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
New insights on the role of free daspartate in the mammalian brain
Francesco Errico et al.
AMINO ACIDS (2012)
Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics
Angelo Bifone et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
A robust experimental protocol for pharmacological fMRI in rats and mice
Livia Ferrari et al.
JOURNAL OF NEUROSCIENCE METHODS (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Klas R. Linderholm et al.
SCHIZOPHRENIA BULLETIN (2012)
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA BULLETIN (2012)
Capturing the Angel in Angel Dust: Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
Bita Moghaddam et al.
SCHIZOPHRENIA BULLETIN (2012)
NMDA Receptor and Schizophrenia: A Brief History
Joseph T. Coyle
SCHIZOPHRENIA BULLETIN (2012)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Neurodevelopmental hypothesis of schizophrenia
Michael J. Owen et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Neural Origin of Spontaneous Hemodynamic Fluctuations in Rats under Burst-Suppression Anesthesia Condition
Xiao Liu et al.
CEREBRAL CORTEX (2011)
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate 1-DOPA-induced dyskinesia
Francesco Errico et al.
EXPERIMENTAL NEUROLOGY (2011)
Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay
Francesco Errico et al.
NEUROBIOLOGY OF AGING (2011)
Increased D-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice
Francesco Errico et al.
NEUROBIOLOGY OF AGING (2011)
From maps to mechanisms through neuroimaging of schizophrenia
Andreas Meyer-Lindenberg
NATURE (2010)
No association between the D-aspartate oxidase locus and schizophrenia
Rami Abou Jamra et al.
PSYCHIATRIC GENETICS (2009)
The Neurodevelopmental Hypothesis of Schizophrenia, Revisited
S. Hossein Fatemi et al.
SCHIZOPHRENIA BULLETIN (2009)
D-Aspartate Prevents Corticostriatal Long-Term Depression and Attenuates Schizophrenia-Like Symptoms Induced by Amphetamine and MK-801
Francesco Errico et al.
JOURNAL OF NEUROSCIENCE (2008)
The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons
Francesco Errico et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Increased levels of D-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility
Francesco Errico et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine
Alessandro Gozzi et al.
MAGNETIC RESONANCE IMAGING (2008)
Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat
Alessandro Gozzi et al.
PSYCHOPHARMACOLOGY (2008)
Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia
Caroline Madeira et al.
SCHIZOPHRENIA RESEARCH (2008)
Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia
Yuan Zhou et al.
SCHIZOPHRENIA RESEARCH (2008)
Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine
Alessandro Gozzi et al.
NEUROPSYCHOPHARMACOLOGY (2008)
D-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia
Louise Verrall et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia
Inna Bendikov et al.
SCHIZOPHRENIA RESEARCH (2007)
NMDA receptors and schizophrenia
Lars V. Kristiansen et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus
S. Chiba et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
D-serine signalling in the brain: friend and foe
Magalie Martineau et al.
TRENDS IN NEUROSCIENCES (2006)
A physiological mechanism to regulate D-aspartic acid and NMDA levels in mammals revealed by D-aspartate oxidase deficient mice
Francesco Errico et al.
GENE (2006)
D-aspartate regulates melanocortin formation and function: Behavioral alterations in D-aspartate oxidase-deficient mice
AS Huang et al.
JOURNAL OF NEUROSCIENCE (2006)
Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics
P Seeman et al.
MOLECULAR PSYCHIATRY (2005)
Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels
K Yamada et al.
BIOLOGICAL PSYCHIATRY (2005)
Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
K Hashimoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
PCP: from pharmacology to modelling schizophrenia
BJ Morris et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Decreased serum levels of D-serine in patients with schizophrenia - Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
K Hashimoto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
The endophenotype concept in psychiatry: Etymology and strategic intentions
II Gottesman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Fold prediction and comparative modeling of Bdm1:: a probable α/β hydrolase associated with hot water epilepsy
A Bhaduri et al.
JOURNAL OF MOLECULAR MODELING (2003)
NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D-2 and serotonin 5-HT2 receptors - implications for models of schizophrenia
S Kapur et al.
MOLECULAR PSYCHIATRY (2002)
D-aspartate disposition in neuronal and endocrine tissues: Ontogeny, biosynthesis and release
H Wolosker et al.
NEUROSCIENCE (2000)
分享论文
